SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Propy is a decentralized real-estate market place backed by superior blockchain infrastructure to facilitate real-time unified transaction in order to reduce fraud and redundancy. Propy is the world’s first international real-estate marketplace.

Propy

Propy is trending amid mixed sentiments as traders discuss recent price volatility and potential catalysts. Some community members express frustration with price action and question the project's long-term viability, while others remain optimistic about Propy's role in real-world asset tokenization and anticipate future growth.

Procter & Gamble Co. engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances. The Health Care segment includes oral care products like toothbrushes, toothpaste, and personal health care such as gastrointestinal, rapid diagnostics, respiratory, and vitamins, minerals, and supplements. The Fabric and Home care segment consists of fabric enhancers, laundry additives and detergents, and air, dish, and surface care. The Baby, Feminine and Family Care segment sells baby wipes, diapers, and pants, adult incontinence, feminine care, paper towels, tissues, and toilet paper. The company was founded by William Procter and James Gamble in 1837 and is headquartered in Cincinnati, OH.

Procter & Gamble Co.

Procter & Gamble is trending as the community discusses its recent price action, potential bottom, and upcoming earnings report. Call options activity and LEAPS are being highlighted, while some traders debate the stock's valuation and potential for a run-up. Additionally, some analysts are weighing in with price target adjustments.

ARK Investment Management LLC - ARK Innovation ETF

ARK Innovation ETF

ARKK is trending as investors assess its recent performance and potential for future growth amid discussions around innovation and disruptive technologies. The ETF's holdings, including TSLA, and potential investment strategies are key talking points. Community members are weighing the fund's long-term outlook and debating whether it represents a trading or investment opportunity.

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Humana Inc.

Humana Inc

Humana is trending amidst discussions about its valuation, Medicare Advantage plans, and potential partnerships, particularly with Clover Health. The stock's volatile price action and perceived manipulation are also key talking points among investors. Some analysts suggest the recent pullback is an overreaction and highlight the company's long-term potential and attractive entry points.

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FCEL is trending as investors discuss its potential role in powering AI data centers, particularly given its partnership with ExxonMobil and technology for carbon capture. The community highlights the company's advantageous position with natural gas-based fuel cells amid increasing AI energy demands. Some are drawing comparisons to Bloom Energy's success and anticipating significant upside for FCEL.

Pinterest, Inc. engages in the operation of a pinboard-style photo-sharing website. It allows users to create and manage theme-based image collections such as events, interests, and hobbies. The company was founded by Benjamin Silbermann, Paul C. Sciarra, and Evan Sharp in October 2008 and is headquartered in San Francisco, CA.

Pinterest Inc - Ordinary Shares - Class A

Pinterest Inc

Pinterest ($PINS) is trending as investors digest recent earnings and analyst ratings, with community members debating its potential versus competitors like Reddit ($RDDT). Positive remarks and strong fund holdings are noted, though some express concerns about market cap and historical performance. Upcoming earnings are highly anticipated as a potential catalyst for significant stock movement.

eCash (XEC) is a Layer-1 digital cash network, developed by Bitcoin ABC. It was created on Nov 15th, 2020, and has since distinguished itself from its predecessors and other Bitcoin clients by integrating the breakthrough Avalanche consensus with its core proof-of-work (PoW) layer, extending its security and fundamental capabilities.  This hybrid consensus integration gives it unique properties for a Bitcoin-like chain, such as interoperability, staking rewards, real-time processing, and an improved overall extensibility, which is hard to achieve in a completely trustless manner using only Nakamoto consensus.  The development roadmap is set with three main goals: Scaling transaction throughput from ~100 tps to more than 5.000.000 tps Improving the payment experience with a less than 3 second transaction finality time Extending the protocol and establishing fork-free upgrade routines, allowing for more rapid, iterative development

eCash

eCash is trending as the community discusses the upcoming Avalanche Pre-Consensus upgrade, promising instant finality and faster transactions. Content from the Electronic Cash Conference (ECC) 2025 is also driving interest, with talks covering scalability, scripting, and the network's vision for peer-to-peer electronic cash. Community members are highlighting staking opportunities and new ecosystem tools.

Tidal Trust II - Defiance Daily Target 2X Long HIMS ETF

Defiance Daily Target 2X Long HIMS ETF

Defiance Daily Target 2X Long HIMS ETF ($HIMZ) is trending as traders discuss potential bounce plays and rebounds, with some expressing bullish sentiment. Community members are actively analyzing technical indicators and potential support levels for entry points, while also weighing the impact of $HIMS earnings and JPMorgan Chase's increased ownership. Some traders are discussing using $HIMZ to play swings and capitalize on the volatility of $HIMS.

BlackRock Institutional Trust Company N.A. - iShares Russell 1000 Growth ETF

iShares Russell 1000 Growth ETF

IWF is trending amid discussions about growth versus value stocks and potential rotations in market leadership. Options activity suggests some investors anticipate continued upside, while others are hedging against potential declines. Community members are analyzing technical indicators and ETF flows to gauge the strength and direction of the Russell 1000 Growth ETF.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Johnson & Johnson is trending as the community discusses recent legal developments, including a $966 million verdict in a talc-related cancer case and a potential link between Tylenol and autism, which has drawn attention from influential figures. Traders are weighing the potential impact of these issues alongside the company's financials, pipeline updates, and strategic moves like the potential spin-off of its orthopedics business, as well as potential acquisitions of other pharmaceutical companies to offset revenues.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Intuitive Surgical, Inc. (ISRG) Q3 Earnings and Revenues Top Estimates

Intuitive Surgical (ISRG) delivered earnings and revenue surprises of +20.60% and +3.92%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

CVRx (CVRX) Surges 19.0%: Is This an Indication of Further Gains?

CVRx (CVRX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

InspireMD Launches CGuard Prime Carotid Stent System in the U.S.

NSPR unveils FDA-approved CGuard Prime in the United States, targeting safer carotid procedures and stroke prevention.

Shares of InspireMD, Inc. (NSPR) dipped nearly 1% on Friday morning after it <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.inspiremd.com/en/press-center/inspiremd-reports-first-quarter-2025-financial-results/">reported</a> a wider-than-expected first quarter (Q1) loss.The company’s revenue for the quarter increased 1.2% year-on-year (YoY) to $1.52 million, above an analyst estimate of $1.45 billion, as per Finchat data.The marginal increase in revenue was driven by the continued adoption of the company’s CGuard technology in existing markets. It was offset by the impact of foreign exchange and distributors managing inventory levels in anticipation of an approval for CGuard Prime in Europe.InspireMD’s CGuard Prime carotid stent system is used to treat carotid artery disease and prevent stroke.Net loss per share came in at $0.22, compared to a net loss of $0.21 per share for the same period in 2024, but wider than an estimated loss of $0.2.The company said that it is continuing to engage with the U.S. Food and Drug Administration (FDA) regarding the application it submitted to obtain marketing approval for the CGuard Prime carotid stent system.The company also expressed optimism about approval for the system in the third quarter of 2025.CEO Marvin Slosman said that the firm’s commercial team is ready to execute at scale upon receiving FDA approval for the technology.“We continue to work interactively with the FDA and are optimistic for an anticipated approval of CGuard Prime in the third quarter of 2025. Despite dynamics within the agency and the timing of our audit in February, we are confident the remaining items will be successfully completed,” he said.On Stocktwits, retail sentiment around InspireMD stayed unmoved within the ‘bullish’ territory over the past 24 hours while message volume remained at ‘high’ levels.&nbsp; &nbsp;<figure class="image"><img style="aspect-ratio:629/62;" src="https://news.stocktwits-cdn.com/Screenshot_2025_05_09_at_11_03_25_AM_png_e35692eebb.webp" alt="NSPR's Sentiment Meter and Message Volume as of 11 a.m. ET on May 9, 2025 | Source: Stocktwits" width="629" height="62"><figcaption>NSPR's Sentiment Meter and Message Volume as of 11 a.m. ET on May 9, 2025 | Source: Stocktwits</figcaption></figure><a href="https://stocktwits.com/symbol/NSPR">NSPR stock</a> is down by about 3% this year but up by nearly 17% over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/ocugen-reports-lower-than-expected-q1-loss/chiWHRQRblX">Ocugen Stock Rises On Better-Than-Feared Q1 Loss: Retail Turns Bullish</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

A candlestick chart is opened in a trading platform on a smartphone. Photo: Silas Stein/dpa (Photo by Silas Stein/picture alliance via Getty Images)

InspireMD Stock Dips On Wider-Than-Expected Q1 Loss, But Retail Is Optimistic

The company’s revenue increased marginally to $1.52 million, driven by the continued adoption of its CGuard technology in existing markets.

Equity

InspireMD to Present at the 23rd Annual Needham Virtual Healthcare Conference

TEL AVIV, Israel and MIAMI, April 03, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard Embolic Prevention Stent System (EPS) for the prevention of stroke, today...

InspireMD Announces Abstract of One-Year Follow-Up Results from the C-GUARDIANS U.S. Investigational Device Exemption (IDE) Clinical Trial Accepted for Presentation at LINC 2024

TEL AVIV, Israel and MIAMI, March 26, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard Embolic Prevention Stent System (EPS) for the prevention of stroke, today...

InspireMD Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

- Record fourth quarter 2023 CGuard EPS revenue of $1.76 million increased 71.6% over fourth quarter 2022 - - Announced positive 30-day data from the Company's ongoing U.S. Investigational Device...

Avance de ganancias de InspireMD

El mi rcoles, 06 de marzo, InspireMD (NASDAQ:NSPR) publicar su ltimo informe de ganancias. Analiza la noticia con ayuda de Benzinga.
Ingresos netos, ganancias y beneficios por acci n
Las ganancias...

InspireMD to Report Fourth Quarter and Full-Year 2023 Financial Results and Provide Corporate Business Update on Wednesday, March 6th

-Conference call and webcast to be held at 8:30 a.m. EST- TEL AVIV, Israel and MIAMI, Feb. 28, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard...

InspireMD Appoints Principal Investigators for C-GUARDIANS II Clinical Trial of the SwitchGuard  Neuroprotection System

Development of SwitchGuard consistent with Company's mission to uniquely support both Carotid Artery Stenting (CAS) and Transcarotid Artery Revascularization (TCAR) procedures with best-in-class...

InspireMD, Inc. is medical device company, which engages in the development and commercialization of its proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. Its products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. The company was founded in 2005 and is headquartered in Miami, FL.

InspireMD Inc

Will Palantir ($PLTR) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Palantir Technologies Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

NSPR
InspireMD Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest NSPR News

NSPRInspireMD Inc